DK1682491T3 - Usymmetrisk geleringsmiddel - Google Patents
Usymmetrisk geleringsmiddelInfo
- Publication number
- DK1682491T3 DK1682491T3 DK04775017.9T DK04775017T DK1682491T3 DK 1682491 T3 DK1682491 T3 DK 1682491T3 DK 04775017 T DK04775017 T DK 04775017T DK 1682491 T3 DK1682491 T3 DK 1682491T3
- Authority
- DK
- Denmark
- Prior art keywords
- unsymmetrical
- gelator
- gelling agent
- thickener
- present
- Prior art date
Links
- 239000003349 gelling agent Substances 0.000 title 1
- 239000002562 thickening agent Substances 0.000 abstract 3
- 239000000463 material Substances 0.000 abstract 2
- 239000011149 active material Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000008719 thickening Effects 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/29—Chiral phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/291—Gel sorbents
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Ceramic Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Structural Engineering (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Materials For Medical Uses (AREA)
- Fire-Extinguishing Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03078599 | 2003-11-12 | ||
| PCT/NL2004/000723 WO2005047231A1 (en) | 2003-11-12 | 2004-10-14 | Non-symmetrical gelling agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1682491T3 true DK1682491T3 (da) | 2011-05-09 |
Family
ID=34585883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04775017.9T DK1682491T3 (da) | 2003-11-12 | 2004-10-14 | Usymmetrisk geleringsmiddel |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7534915B2 (da) |
| EP (1) | EP1682491B1 (da) |
| JP (1) | JP4741505B2 (da) |
| CN (1) | CN100453528C (da) |
| AT (1) | ATE497489T1 (da) |
| CA (1) | CA2544814C (da) |
| DE (1) | DE602004031301D1 (da) |
| DK (1) | DK1682491T3 (da) |
| WO (1) | WO2005047231A1 (da) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100453528C (zh) | 2003-11-12 | 2009-01-21 | 应用超微系统股份有限公司 | 非对称胶凝剂 |
| US7560587B2 (en) | 2004-12-04 | 2009-07-14 | Xerox Corporation | Bis[urea-urethane] compounds |
| US7153349B2 (en) | 2004-12-04 | 2006-12-26 | Xerox Corporation | Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7220300B2 (en) | 2004-12-04 | 2007-05-22 | Xerox Corporation | Phase change inks containing bis(urea-urethane) compounds |
| US7314949B2 (en) | 2004-12-04 | 2008-01-01 | Xerox Corporation | Trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7576235B2 (en) | 2004-12-04 | 2009-08-18 | Xerox Corporation | Processes for preparing bis(urea-urethane) compounds |
| US7144450B2 (en) | 2004-12-04 | 2006-12-05 | Xerox Corporation | Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7317122B2 (en) | 2004-12-04 | 2008-01-08 | Xerox Corporation | Curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
| EP1800694A1 (en) | 2005-12-23 | 2007-06-27 | Applied NanoSystems B.V. | Controlled release gels |
| JP4871640B2 (ja) * | 2006-05-17 | 2012-02-08 | 花王株式会社 | 環状イミド化合物 |
| KR101557814B1 (ko) | 2007-07-05 | 2015-10-06 | 닛산 가가쿠 고교 가부시키 가이샤 | 신규 지질트리펩티드성 히드로겔화제 및 히드로겔 |
| US20110263545A1 (en) | 2008-05-20 | 2011-10-27 | Naweed Muhammad | Hepatoprotectant acetaminophen mutual prodrugs |
| US20110229565A1 (en) | 2008-09-17 | 2011-09-22 | Karp Jeffrey M | Drug Delivery Composition Comprising a Self-Assembled Gelator |
| CA2792767C (en) * | 2010-03-12 | 2014-07-08 | The Procter & Gamble Company | Ph tuneable amido-gellant for use in consumer product compositions |
| US8207107B2 (en) * | 2010-03-12 | 2012-06-26 | The Procter & Gamble Company | Di-amido gellant for use in consumer product compositions |
| US20120004310A1 (en) * | 2010-05-28 | 2012-01-05 | Longo Frank M | Non-peptide bdnf neurotrophin mimetics |
| JP2013540757A (ja) | 2010-09-24 | 2013-11-07 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | カプセル化された作用物質の放出を制御する能力を有するナノ構造ゲル |
| US10093674B2 (en) | 2011-05-31 | 2018-10-09 | Brandeis University | Supramolecular nanofibers and hydrogels based on nucleic acids functionalized with nucleobases |
| WO2012166706A2 (en) * | 2011-05-31 | 2012-12-06 | Brandeis University | Supramolecular nanofibers and hydrogels based on oligopeptides functionalized with nucleobases |
| US20130303427A1 (en) * | 2011-09-13 | 2013-11-14 | Susana Fernandez Prieto | MICROCAPSULE COMPOSITIONS COMPRISING pH TUNEABLE DI-AMIDO GELLANTS |
| CA2901844A1 (en) | 2013-03-15 | 2014-09-18 | Pharmatrophix, Inc. | Non-peptide bdnf neurotrophin mimetics |
| CN105189449A (zh) | 2013-03-15 | 2015-12-23 | 特罗菲克斯制药股份有限公司 | 非肽bdnf神经营养蛋白模拟物 |
| US9789043B2 (en) | 2013-12-06 | 2017-10-17 | Daicel Corporation | Thickening stabilizer and thickening/stabilizing composition using the same |
| AU2016250662A1 (en) * | 2015-04-23 | 2017-11-16 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| US9962339B2 (en) | 2015-10-08 | 2018-05-08 | The Brigham And Women's Hospital, Inc. | Stabilized assembled nanostructures for delivery of encapsulated agents |
| EP3978022A1 (en) | 2016-05-06 | 2022-04-06 | The Brigham and Women's Hospital, Inc. | Binary self assembled gels for controlled delivery of encapsulated agents to cartilage |
| WO2018144991A1 (en) | 2017-02-03 | 2018-08-09 | The Brigham And Women's Hospital, Inc. | Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof |
| US10881745B2 (en) | 2017-05-08 | 2021-01-05 | Alivio Therapeutics, Inc. | Formulation of nanostructured gels for increased agent loading and adhesion |
| HRP20221180T1 (hr) * | 2018-12-17 | 2022-12-09 | Rudjer Boskovic Institute | Sastav koji sadrži oksalamidni gelator i biljno ulje |
| CN111729622A (zh) * | 2020-04-22 | 2020-10-02 | 上海交通大学医学院附属第九人民医院 | 一种苯丙氨酸衍生的手性超分子水凝胶及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08231942A (ja) * | 1995-02-24 | 1996-09-10 | Nisshin Oil Mills Ltd:The | 有機液体のゲル化または固化剤 |
| JP3641143B2 (ja) * | 1998-09-01 | 2005-04-20 | 日清オイリオグループ株式会社 | ベンゼンカルボン酸アミド化合物、および有機液体のゲル化または固化剤 |
| AU2844100A (en) * | 1998-12-15 | 2000-07-03 | Yale University | Association of compounds in carbon dioxide and the gels and/or foams formed therefrom |
| FR2811552B1 (fr) * | 2000-07-17 | 2002-12-27 | Oreal | Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide |
| WO2003084508A1 (en) | 2002-04-04 | 2003-10-16 | Applied Nanosystems B.V. | Delivery of a substance to a pre-determined site |
| EP1364941A1 (en) * | 2002-05-22 | 2003-11-26 | Applied NanoSystems B.V. | Gelling agents |
| CN100453528C (zh) | 2003-11-12 | 2009-01-21 | 应用超微系统股份有限公司 | 非对称胶凝剂 |
-
2004
- 2004-10-14 CN CNB200480040295XA patent/CN100453528C/zh not_active Expired - Fee Related
- 2004-10-14 AT AT04775017T patent/ATE497489T1/de not_active IP Right Cessation
- 2004-10-14 WO PCT/NL2004/000723 patent/WO2005047231A1/en not_active Ceased
- 2004-10-14 JP JP2006539409A patent/JP4741505B2/ja not_active Expired - Fee Related
- 2004-10-14 EP EP04775017A patent/EP1682491B1/en not_active Expired - Lifetime
- 2004-10-14 CA CA2544814A patent/CA2544814C/en not_active Expired - Fee Related
- 2004-10-14 DK DK04775017.9T patent/DK1682491T3/da active
- 2004-10-14 DE DE602004031301T patent/DE602004031301D1/de not_active Expired - Lifetime
-
2006
- 2006-05-11 US US11/432,735 patent/US7534915B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN100453528C (zh) | 2009-01-21 |
| CN1902160A (zh) | 2007-01-24 |
| EP1682491B1 (en) | 2011-02-02 |
| CA2544814C (en) | 2013-05-14 |
| EP1682491A1 (en) | 2006-07-26 |
| CA2544814A1 (en) | 2005-05-26 |
| JP4741505B2 (ja) | 2011-08-03 |
| DE602004031301D1 (de) | 2011-03-17 |
| JP2007510791A (ja) | 2007-04-26 |
| ATE497489T1 (de) | 2011-02-15 |
| US20060276676A1 (en) | 2006-12-07 |
| US7534915B2 (en) | 2009-05-19 |
| WO2005047231A1 (en) | 2005-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1682491T3 (da) | Usymmetrisk geleringsmiddel | |
| ATE296094T1 (de) | Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen | |
| BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
| ATE446313T1 (de) | Muteine von tränen-lipocalin | |
| BR0209777A (pt) | Formulações lìquidas estáveis | |
| BRPI0507680A (pt) | partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas | |
| ATE415817T1 (de) | Agrochemische formulierungen | |
| DK1294413T3 (da) | Spröjtbare sammensætninger til sårpleje | |
| DK1264602T3 (da) | Farmaceutiske præparater | |
| DE602005023755D1 (de) | Indolonderivate, verfahren zu deren herstellung und deren anwendungen | |
| ATE426400T1 (de) | Wirkstoffhaltige filmfírmige zubereitungen mit verbesserter chemischer stabilitat, und verfahren zu deren herstellung | |
| DK1519944T3 (da) | Fremgangsmåder til fremstilling af fibrinogen | |
| ATE316101T1 (de) | Thrombinspaltbare faktor-x-analoga | |
| BRPI0620431A8 (pt) | uso de um poliuretano formador de película, preparação farmacêutica líquida, aplicador e emplastro contendo a referida preparação farmacêutica | |
| ATE329910T1 (de) | 5-trityloxymethyl-2-oxazolidinon und verfahren zu dessen herstellung | |
| EA200601288A1 (ru) | Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение | |
| DK1139980T3 (da) | Kosmetisk eller medicinsk praparat til topisk anvendelse | |
| ATE548343T1 (de) | Umsetzungsprodukte von 2-propylheptanol mit 1- halogen-2,3-epoxypropanen und 1-hydroxy-2,3- epoxypropan | |
| BR0007952A (pt) | Agente para tratamento capilar | |
| UY29999A1 (es) | "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones" | |
| DE602006015449D1 (de) | Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung | |
| SE0102910D0 (sv) | New use | |
| BR0314624A (pt) | Revestimento, processo de preparação e uso deste em suporte de madeira | |
| ATE460168T1 (de) | Nicht-radioaktives strontiummittel zur behandlung von krebs | |
| ATE487492T1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit |